Latest filing published 15 Dec 2017 for Aurinia Pharmaceuticals Inc., €778.
Filing timeline
BuySaleInsider track record
Vassiliki Nichole (celia) Economides: trading record in brief
Vassiliki Nichole (celia) Economides discloses dealings in Aurinia Pharmaceuticals Inc. to SEC (Form 4). Between 24 October 2017 and 15 December 2017, the trades on record add up to 2 filings.
No open-market sale appears; the market trades are 2 purchases worth €7,455. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
The record was last updated on 15 December 2017 with an open-market purchase (€778) in Aurinia Pharmaceuticals Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Vassiliki Nichole (celia) Economides
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 250 shares@ CA$4.6910.4% of flowCommon SharesTSXSEDI:3099243Canonical exit: 15 Mar 2018 (T+90)
- 1,750 shares@ CA$5.686989.6% of flowCommon SharesTSXSEDI:3074110Canonical exit: 22 Jan 2018 (T+90)
2 of 2 declarations
